Chimeric antigen receptor–T cell therapy manufacturing: modelling the effect of offshore production on aggregate cost of goods
Cell and gene therapies have demonstrated excellent clinical results across a range of indications with chimeric antigen receptor (CAR)–T cell therapies among the first to reach market. Although these therapies are currently manufactured using patient-derived cells, therapies using healthy donor cel...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Default Article |
Published: |
2019
|
Subjects: | |
Online Access: | https://hdl.handle.net/2134/37113 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|